Profile | GDS4284 / 208287_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 150.225 | 44 |
GSM687648 | Patient 402 control | 14.5308 | 9 |
GSM687653 | Patient 403 control | 194.353 | 49 |
GSM687658 | Patient 404 control | 77.2658 | 29 |
GSM687663 | Patient 411 control | 112.914 | 35 |
GSM687668 | Patient 422 control | 222.303 | 51 |
GSM687673 | Patient 424 control | 71.8845 | 27 |
GSM687678 | Patient 425 control | 17.6487 | 10 |
GSM687683 | Patient 427 control | 46.0217 | 21 |
GSM687688 | Patient 428 control | 144.962 | 42 |
GSM687695 | Patient 441 control | 66.3162 | 19 |
GSM687699 | Patient 443 control | 175.819 | 42 |
GSM687704 | Patient 444 control | 30.7987 | 17 |
GSM687707 | Patient 448 control | 367.845 | 58 |
GSM687712 | Patient 449 control | 180.154 | 46 |
GSM687719 | Patient 450 control | 190.299 | 44 |
GSM687724 | Patient 451 control | 154.785 | 40 |
GSM687728 | Patient 452 control | 142.706 | 40 |
GSM687646 | Patient 401 treated 24h | 59.6448 | 26 |
GSM687649 | Patient 402 treated 24h | 90.6901 | 35 |
GSM687665 | Patient 411 treated 24h | 120.995 | 36 |
GSM687651 | Patient 402 treated 4 weeks | 101.448 | 33 |
GSM687667 | Patient 411 treated 4 weeks | 198.96 | 48 |
GSM687670 | Patient 422 treated 24h | 85.7902 | 30 |
GSM687671 | Patient 422 treated 4 weeks | 12.6428 | 8 |
GSM687654 | Patient 403 treated 24h | 164.359 | 46 |
GSM687675 | Patient 424 treated 24h | 129.62 | 37 |
GSM687685 | Patient 427 treated 24h | 204.251 | 48 |
GSM687656 | Patient 403 treated 4 weeks | 23.9253 | 16 |
GSM687677 | Patient 424 treated 4 weeks | 96.5235 | 34 |
GSM687687 | Patient 427 treated 4 weeks | 172.087 | 47 |
GSM687692 | Patient 428 treated 4h | 193.684 | 47 |
GSM687716 | Patient 449 treated 4h | 245.433 | 53 |
GSM687722 | Patient 450 treated 4h | 27.0683 | 12 |
GSM687680 | Patient 425 treated 24h | 76.927 | 30 |
GSM687690 | Patient 428 treated 24h | 20.1828 | 12 |
GSM687700 | Patient 443 treated 24h | 40.5669 | 14 |
GSM687705 | Patient 444 treated 24h | 222.834 | 52 |
GSM687714 | Patient 449 treated 24h | 160.949 | 46 |
GSM687721 | Patient 450 treated 24h | 36.8603 | 16 |
GSM687682 | Patient 425 treated 4 weeks | 114.504 | 38 |
GSM687694 | Patient 428 treated 4 weeks | 95.6651 | 35 |
GSM687702 | Patient 443 treated 4 weeks | 78.369 | 28 |
GSM687718 | Patient 449 treated 4 weeks | 158.126 | 43 |
GSM687723 | Patient 450 treated 4 weeks | 147.215 | 41 |
GSM687661 | Patient 404 treated 4h | 43.0234 | 20 |
GSM687710 | Patient 448 treated 4h | 109.082 | 36 |
GSM687726 | Patient 451 treated 4h | 41.777 | 19 |
GSM687730 | Patient 452 treated 4h | 696.779 | 65 |
GSM687660 | Patient 404 treated 24h | 30.2475 | 12 |
GSM687697 | Patient 441 treated 24h | 32.2054 | 12 |
GSM687709 | Patient 448 treated 24h | 252.927 | 52 |
GSM687725 | Patient 451 treated 24h | 305.399 | 54 |
GSM687729 | Patient 452 treated 24h | 396.258 | 58 |
GSM687727 | Patient 451 treated 4 weeks | 433.179 | 60 |
GSM687731 | Patient 452 treated 4 weeks | 138.985 | 38 |